Rituximab for immune hemolytic anemia following T- and b-cell-depleted hematopoietic stem cell transplantation

P. Corti, S. Bonanomi, C. Vallinoto, A. Balduzzi, C. Uderzo, G. Cazzaniga, G. Gaipa, M. Dassi, P. Perseghin, Attilio Rovelli

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

The treatment of immune-mediated hemolytic anemia (IHA) complicating hem atopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred after T-and B-cell depleted unrelated donor HSCT carried out for mucopolysaccharidosis type I-H (Hurler syndrome) which was successfully treated with anti-CD20+ monoclonal antibody.

Original languageEnglish
Pages (from-to)43-45
Number of pages3
JournalActa Haematologica
Volume109
Issue number1
DOIs
StatePublished - 2003
Externally publishedYes

Keywords

  • Hematopoietic stem cell transplantation
  • Hurler syndrome
  • Immune hemolytic anemia
  • Storage diseases

Fingerprint

Dive into the research topics of 'Rituximab for immune hemolytic anemia following T- and b-cell-depleted hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

Cite this